Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Combined Memantine (Namenda) Plus Escitalopram (Lexapro) Treatment in Elderly Depressed Patients With Cognitive Impairment

NCT01876823 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT01876823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01876823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Combined Memantine (Namenda) Plus Escitalopram (Lexapro) Treatment in Elderly Depressed Patients With Cognitive Impairment
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 2/3
Overall status
Completed
Start date
April 30, 2006
Completion date
March 31, 2010
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, major depressive disorder, mild cognitive impairment